Safe use of proton pump inhibitors in patients with cirrhosis

AIMS: Proton pump inhibitors (PPIs) belong to the most frequently used drugs, also in patients with cirrhosis. PPIs are extensively metabolized by the liver, but practice guidance on prescribing in cirrhosis is lacking. We aim to develop practical guidance on the safe use of PPIs in patients with ci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Weersink, Rianne A., Bouma, Margriet, Burger, David M., Drenth, Joost P.H., Harkes‐Idzinga, S. Froukje, Hunfeld, Nicole G.M., Metselaar, Herold J., Monster‐Simons, Margje H., van Putten, Sandra A.W., Taxis, Katja, Borgsteede, Sander D.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6046475/
https://ncbi.nlm.nih.gov/pubmed/29688583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados